ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy.

Eduardo Huarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.